Whole genome sequencing of Escherichia coli from patients with urinary tract infections and sepsis

The Australian Centre for Genomic Epidemiological Microbiology (AusGEM) is using genomic sequencing to characterise Escherichia coli that cause urinary tract infections and sepsis in Australian hospitals.

Lead organisation(s):

AusGEM (Partnership between University of Technology and NSW Department of Primary Industries).

Project type:

AusGEM’s studies are focusing on the carriage of mobile antimicrobial resistance (AMR) genes and virulence genes in these cohorts. Comparing these elements with those circulating in food production systems and from environmental and wildlife sources enables policy makers to make informed regulatory choices regarding antimicrobials and biosecurity.

AusGEM Phases 1 and 2 ran from 2014 to March 2020. AusGEM Phase 3 is scheduled to commence in 2020 and will conclude in 2024
For more information on this research or activity:

Are you the owner of this research? If you want to update or request removal please email amr.website@health.gov.au or use the Register update form.

Last updated:

Help us improve our website

If you would like a response please use the Feedback form instead.